Tahany Ghareeb, S. El-toumy, Hussieny Elgendy, E. Haggag
{"title":"Secondary Metabolites and Hepatoprotective Activity of Euphorbia retusa","authors":"Tahany Ghareeb, S. El-toumy, Hussieny Elgendy, E. Haggag","doi":"10.21608/APRH.2018.4312.1060","DOIUrl":null,"url":null,"abstract":"Objectives: This study aimed to explore the secondary metabolites from the methanolic extract of Euphorbia retusa forssk, as it is known for its use in folk medicine and for being rich in bioactive molecules. Methods: The methanolic extractwas fractionated by different chromatographic techniques and the structures of the isolated compounds were elucidated by UV, 1H and 13C NMR spectroscopy. Hepatoprotective activity of E. retusa extract was evaluated on CCl4-induced liver damage in rats through biochemical assessment of serum ALT as well as MDA, GSH and NO. It was also evaluated through histopathological study of liver autopsy samples. Results: From the aqueous methanolic extract of Euphorbia retusa forssk. aerial parts seven known phenolic compounds; kamferol-3-O-β-D- glucopyranoside (1), quercetin -3-O-β-D- glucopyranoside (2), 3,3`dimethoxy ellagic acid (3), ellagic acid (4), gallic acid (5), kamferol (6) and quercetin (7) were isolated and identified by chromatographic and spectroscopic analysis. Administration of the extract (100 and 200 mg/kg body weight) significantly decreased the AST and ALT levels, inhibited the CCl4 -induced elevated levels of NO and MDA and increased the level of hepatic GSH. A comparative histopathological study of liver exhibited almost nearly normal architecture as compared to toxicant group. Conclusion: Euphorbia retusaextract has shown to have hepatoprotective activityon CCl4-induced liver damage in rats which might be attributed to its phenolic contents.","PeriodicalId":15017,"journal":{"name":"Journal of Advanced Pharmacy Research","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Advanced Pharmacy Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/APRH.2018.4312.1060","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
Abstract
Objectives: This study aimed to explore the secondary metabolites from the methanolic extract of Euphorbia retusa forssk, as it is known for its use in folk medicine and for being rich in bioactive molecules. Methods: The methanolic extractwas fractionated by different chromatographic techniques and the structures of the isolated compounds were elucidated by UV, 1H and 13C NMR spectroscopy. Hepatoprotective activity of E. retusa extract was evaluated on CCl4-induced liver damage in rats through biochemical assessment of serum ALT as well as MDA, GSH and NO. It was also evaluated through histopathological study of liver autopsy samples. Results: From the aqueous methanolic extract of Euphorbia retusa forssk. aerial parts seven known phenolic compounds; kamferol-3-O-β-D- glucopyranoside (1), quercetin -3-O-β-D- glucopyranoside (2), 3,3`dimethoxy ellagic acid (3), ellagic acid (4), gallic acid (5), kamferol (6) and quercetin (7) were isolated and identified by chromatographic and spectroscopic analysis. Administration of the extract (100 and 200 mg/kg body weight) significantly decreased the AST and ALT levels, inhibited the CCl4 -induced elevated levels of NO and MDA and increased the level of hepatic GSH. A comparative histopathological study of liver exhibited almost nearly normal architecture as compared to toxicant group. Conclusion: Euphorbia retusaextract has shown to have hepatoprotective activityon CCl4-induced liver damage in rats which might be attributed to its phenolic contents.
目的:研究大戟甲醇提取物的次生代谢产物,大戟甲醇提取物具有丰富的生物活性分子,在民间医学中具有广泛的应用价值。方法:采用不同的色谱技术对甲醇提取物进行分馏,并用紫外、1H和13C NMR对分离得到的化合物进行结构鉴定。通过血清ALT、丙二醛(MDA)、谷胱甘肽(GSH)和一氧化氮(NO)的生化测定,评价蛇麻提取物对ccl4所致大鼠肝损伤的保护作用。通过肝脏解剖样本的组织病理学研究也对其进行了评估。结果:从大戟乙醇水提物中提取。航空部分七种已知酚类化合物;分离得到kamferol-3- o -β- d - glucopyranoside(1)、槲皮素-3- o -β- d - glucopyranoside(2)、3,3 '二甲氧基鞣花酸(3)、鞣花酸(4)、没食子酸(5)、kamferol(6)和槲皮素(7)。100和200 mg/kg体重组显著降低AST和ALT水平,抑制CCl4诱导的NO和MDA水平升高,提高肝脏GSH水平。肝脏的比较组织病理学研究显示,与中毒组相比,肝脏的结构几乎正常。结论:大戟提取物对ccl4所致大鼠肝损伤具有保护作用,其机制可能与其酚类物质有关。